win 57273 has been researched along with carbostyril in 21 studies
| Studies (win 57273) | Trials (win 57273) | Recent Studies (post-2010) (win 57273) | Studies (carbostyril) | Trials (carbostyril) | Recent Studies (post-2010) (carbostyril) |
|---|---|---|---|---|---|
| 23 | 0 | 0 | 12,855 | 1,323 | 5,611 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 20 (95.24) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett, MS; Erwin, ME; Jones, RN; Koontz, FP | 1 |
| Finegold, SM; Molitoris, E; Wexler, HM | 1 |
| Aldridge, KE | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
| Furet, YX; Lucain, C; Pechère, JC | 1 |
| Citron, DM; Goldstein, EJ | 1 |
| Cohen, Y; Grosset, J; Perronne, C; Pocidalo, JJ; Truffot-Pernot, C; Vilde, JL | 1 |
| Gelber, RH; Iranmanesh, A; Murray, L; Siu, P; Tsang, M | 1 |
| Forstall, GJ; Knapp, CC; Washington, JA | 1 |
| Chin, NX; Neu, HC | 1 |
| Grosset, J; Ji, B; Truffot-Pernot, C | 1 |
| Cartwright, FD; Kenny, GE | 2 |
| Heifets, LB; Lindholm-Levy, PJ | 1 |
| Kaatz, GW; Seo, SM | 1 |
| Echols, RM; Robbiano, EM; Venezia, RA; Yocum, DM | 1 |
| Barry, AL; Jones, RN | 1 |
| Deuel, DM; Dobson, RA; Lesher, GY; Rake, JB; Sedlock, DM | 1 |
| Eliopoulos, GM; Ferraro, MJ; Klimm, K; Moellering, RC; Rice, LB | 1 |
| Edelstein, MA; Edelstein, PH | 1 |
| Mehl, P; Noskin, GA; Warren, JR | 1 |
21 other study(ies) available for win 57273 and carbostyril
| Article | Year |
|---|---|
CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum.
Topics: Anti-Bacterial Agents; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium chelonae; Nontuberculous Mycobacteria; Quinolones | 1992 |
In vitro activities of three of the newer quinolones against anaerobic bacteria.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones | 1992 |
In vitro antistaphylococcal activities of two investigative fluoroquinolones, CI-960 and WIN 57273, compared with those of ciprofloxacin, mupirocin (pseudomonic acid), and peptide-class antimicrobial agents.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mupirocin; Quinolones; Staphylococcus | 1992 |
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Quinolones; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 1992 |
Relative beta-lactamase- and transpeptidase-inhibitory activities of the new quinolone WIN-57273 in Staphylococcus aureus.
Topics: Anti-Infective Agents; beta-Lactamase Inhibitors; Fluoroquinolones; Microbial Sensitivity Tests; Peptidyl Transferases; Quinolones; Staphylococcus aureus | 1992 |
Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones | 1992 |
Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages.
Topics: Anti-Infective Agents; Clarithromycin; Drug Combinations; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium avium; Quinolones | 1992 |
Activities of various quinolone antibiotics against Mycobacterium leprae in infected mice.
Topics: Animals; Anti-Infective Agents; Female; Fluoroquinolones; Leprosy; Mice; Mice, Inbred BALB C; Mycobacterium leprae; Pefloxacin; Quinolones | 1992 |
Activity of new quinolones against ciprofloxacin-resistant staphylococci.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Staphylococcus | 1991 |
In-vitro activity of WIN 57273 compared to the activity of other fluoroquinolones and two beta-lactam antibiotics.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Ciprofloxacin; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones | 1991 |
In vitro and in vivo activities of sparfloxacin (AT-4140) against Mycobacterium tuberculosis.
Topics: Animals; Anti-Infective Agents; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Quinolones; Tuberculosis | 1991 |
Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin.
Topics: Anti-Infective Agents; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Ofloxacin; Quinolones; Tetracycline | 1991 |
Susceptibilities of Mycoplasma hominis and Ureaplasma urealyticum to two new quinolones, sparfloxacin and WIN 57273.
Topics: Anti-Infective Agents; Fluoroquinolones; Microbial Sensitivity Tests; Mycoplasma; Ofloxacin; Quinolones; Tetracycline; Ureaplasma | 1991 |
MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis.
Topics: Anti-Infective Agents; Ciprofloxacin; Culture Media; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium tuberculosis; Ofloxacin; Quinolones | 1990 |
WIN 57273, a new fluoroquinolone with enhanced in vitro activity versus gram-positive pathogens.
Topics: 4-Quinolones; Anti-Infective Agents; beta-Lactamases; Drug Resistance, Microbial; Enterococcus faecalis; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Mutation; Quinolones; Staphylococcus aureus; Staphylococcus epidermidis | 1990 |
Comparative in vitro activities of a new quinolone, WIN 57273, and piperacillin plus tazobactam against anaerobic bacteria.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria, Anaerobic; Bacteroides fragilis; beta-Lactamase Inhibitors; Drug Therapy, Combination; Fluoroquinolones; Fusobacterium; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Quinolones; Tazobactam | 1990 |
In vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinolone.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Culture Media; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Mutation; Quinolones | 1990 |
In vitro and in vivo activities of a new quinolone, WIN 57273, possessing potent activity against gram-positive bacteria.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Bacterial Infections; Female; Fluoroquinolones; Gram-Positive Bacteria; Listeriosis; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Quinolones; Staphylococcal Infections; Streptococcal Infections | 1990 |
Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agent.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Drug Resistance, Microbial; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Quinolones | 1990 |
WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Culture Media; Fluoroquinolones; Guinea Pigs; In Vitro Techniques; Legionella; Macrophages; Male; Microbial Sensitivity Tests; Pulmonary Alveoli; Quinolones | 1989 |
Bactericidal activity of the fluoroquinolone WIN 57273 against high-level gentamicin-resistant Enterococcus faecalis.
Topics: Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus faecalis; Fluoroquinolones; Gentamicins; Quinolones; Time Factors | 1993 |